Renaissance Technologies’s Carlsmed CARL Stock Holding History

Renaissance Technologies’s Portfolio CARL Stock Details CARL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,400	Closed	-$94.1K	–	3746
2026 Q1	$94.1K	Sell	10,400 -13,900	-57%	-$168K	﹤0.01%	3038
2025 Q4	$300K	Buy	+24,300	New	+$323K	﹤0.01%	2762

Other funds holding CARL

Jupiter Topco New York $245B AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM Capital Shawnee, Kansas $618M AUM

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies's CARL Position: Q2 2026 in Review

Renaissance Technologies sold out of Carlsmed (CARL) in Q2 2026, closing a stake of 10,400 shares — an estimated $94.1K sold.

Renaissance Technologies first reported a position in CARL in Q4 2025 and held it in 2 quarters. The position peaked at $300K in Q4 2025. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

Renaissance Technologies reported no remaining Carlsmed position as of Q2 2026 after selling out during the quarter.
Renaissance Technologies sold 10,400 Carlsmed shares in Q2 2026, an estimated $94.1K.
Renaissance Technologies first reported a position in Carlsmed in Q4 2025 and held it in 2 quarters.
Renaissance Technologies's Carlsmed position peaked at $300K in Q4 2025.
74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.